BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1303925)

  • 21. Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism.
    Bertoli A; Fusco A; Magnani A; Marini MA; Di Daniele N; Gatti S; Lauro R
    Exp Clin Endocrinol Diabetes; 1995; 103(1):15-20. PubMed ID: 7621099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sclerocystic ovary syndrome].
    Vikhliaeva EM
    Akush Ginekol (Mosk); 1973 Mar; 49(3):54-8. PubMed ID: 4760972
    [No Abstract]   [Full Text] [Related]  

  • 23. [The differential diagnosis of hairy virilism in polycystic ovaries from adrenal cortical hirsutism].
    Maleeva A; Milkov V; Visheva N; Kekhaĭova M
    Vutr Boles; 1990; 29(3):93-9. PubMed ID: 2178292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polycystic ovary syndrome in bulimic women--an evaluation based on the new diagnostic criteria.
    Naessén S; Carlström K; Garoff L; Glant R; Hirschberg AL
    Gynecol Endocrinol; 2006 Jul; 22(7):388-94. PubMed ID: 16864149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of obesity on the clinical and hormonal characteristics of the polycystic ovary syndrome.
    Singh KB; Mahajan DK; Wortsman J
    J Reprod Med; 1994 Oct; 39(10):805-8. PubMed ID: 7837128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of metformin on clinical and biochemical parameters in polycystic ovary syndrome.
    Kriplani A; Agarwal N
    J Reprod Med; 2004 May; 49(5):361-7. PubMed ID: 15214709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Menstrual cycle disorders in polycystic ovary syndrome--ultrasonographic characteristics and hormonal status].
    Radulović A; Bogavac M; Pjević Trninić A
    Med Pregl; 2002; 55(5-6):241-6. PubMed ID: 12170870
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Most women with acne have polycystic ovaries.
    Bunker CB; Newton JA; Kilborn J; Patel A; Conway GS; Jacobs HS; Greaves MW; Dowd PM
    Br J Dermatol; 1989 Dec; 121(6):675-80. PubMed ID: 2532926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigating hirsutism.
    Sathyapalan T; Atkin SL
    BMJ; 2009 Apr; 338():b912. PubMed ID: 19401328
    [No Abstract]   [Full Text] [Related]  

  • 30. [The effect of synthetic gonadotropin releasing hormone on the plasma levels of FH and LSH in women with hirsutism and polycystic ovaries].
    Pjević M; Kovac T; Bujas M; Pusac R
    Jugosl Ginekol Perinatol; 1985; 25(3-4):49-52. PubMed ID: 3938829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hirsutism and androgenic menstrual cycle irregularities].
    Carol W; Wilke I
    Z Arztl Fortbild (Jena); 1991 Feb; 85(3-4):153-7. PubMed ID: 2058208
    [No Abstract]   [Full Text] [Related]  

  • 32. Lack of correlation of ultrasonographically determined ovarian size with age, ponderal index, and hormonal factors in 45 patients with polycystic ovarian disease.
    Futterweit W; Yeh HC; Thornton JC
    Int J Fertil; 1987; 32(6):456-9. PubMed ID: 2891634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Informative values of sequential test expressing adrenal and ovarian suppression in the differential diagnosis of hirsutism complicated by menstrual dysfunction (author's transl)].
    Divila F; Presl J; Stroufová A
    Cesk Gynekol; 1980; 45(10):704-12. PubMed ID: 7471240
    [No Abstract]   [Full Text] [Related]  

  • 34. [Polycystic ovary syndrome I. Clinical presentation and treatment].
    Ovesen PG; Møller N; Greisen S; Ingerslev HJ
    Ugeskr Laeger; 1998 Jan; 160(3):260-4. PubMed ID: 9454393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polycystic ovarian syndrome management options.
    Bates GW; Propst AM
    Obstet Gynecol Clin North Am; 2012 Dec; 39(4):495-506. PubMed ID: 23182556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polycystic ovarian disease.
    Schriock E; Martin MC; Jaffe RB
    West J Med; 1985 Apr; 142(4):519-22. PubMed ID: 3925638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic effects of spironolactone in polycystic ovary syndrome.
    Milewicz A; Silber D; Kirschner MA
    Obstet Gynecol; 1983 Apr; 61(4):429-32. PubMed ID: 6828272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovulatory disorders in women with polycystic ovary syndrome.
    Franks S; Adams J; Mason H; Polson D
    Clin Obstet Gynaecol; 1985 Sep; 12(3):605-32. PubMed ID: 3933879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hormonal-mediator interrelationships in polycystic ovary syndrome].
    Shikaeva FV; Efimenko NF
    Probl Endokrinol (Mosk); 1994; 40(4):33-5. PubMed ID: 7971905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocrine changes after laparoscopic ovarian drilling in clomiphene citrate-resistant women with polycystic ovarian syndrome.
    Al-Ojaimi EH
    Saudi Med J; 2004 Aug; 25(8):1032-9. PubMed ID: 15322594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.